An image-guided biopsy combines medical imaging technology with precise tissue collection techniques. The clinical goal of this procedure is to obtain an adequate diagnostic specimen from an abnormal tissue area, or lesion, while minimizing trauma to adjacent anatomical structures. Under real-time or near-real-time imaging control, an interventional radiologist navigates a fine needle or core biopsy device directly into the target area. The retrieved cells or tissue fragments undergo histopathological evaluation, immunohistochemical staining, and molecular analysis. This procedure plays a pivotal role in contemporary oncology, infectious disease diagnosis, and autoimmune evaluation, serving as a primary pathway for definitive disease identification and therapeutic planning.

The image-guided biopsy procedure follows a strict, standardized clinical workflow to ensure patient safety and diagnostic yield. The patient is placed on the imaging couch in a position determined by the target location (supine, prone, or lateral decubitus). Diagnostic imaging scans are performed to chart an optimal needle trajectory that avoids major vascular structures, nerves, and vulnerable organs. The overlying skin is disinfected using chlorhexidine solution and draped sterilely. Local anaesthetic, typically 1% to 2% lidocaine, is infiltrated from the dermis down through deep fascial planes along the planned needle path.

Under direct real-time imaging or sequential CT scans, the interventional radiologist advances a guide needle or co-axial biopsy cannula into the outer edge of the lesion. Once alignment is verified, a spring-loaded automated core biopsy needle or fine needle aspiration device is inserted through the cannula into the lesion. Tissue cores or cytological aspirates are harvested, placed into preserve containers or fixative media, and immediately checked for adequacy. Following satisfactory collection, the needle assembly is removed, and manual compression is applied to the puncture site for several minutes. A sterile adhesive bandage is applied, and the patient is transferred to the recovery area for observation.

Image-guided biopsy provides significant clinical advantages compared to traditional open surgical diagnostic techniques:

• High Diagnostic Accuracy: Delivers diagnostic accuracy rates ranging between 90% and 98% across solid organs when guided by real-time imaging (ACR-SIR Practice Parameter, 2021).
• Minimally Invasive Profile: Requires only a minor skin entry site, eliminating the need for surgical incisions, extensive tissue disruption, or suturing.
• Reduced Complication Rates: Lowers the risk of major procedural complications, systemic infection, and perioperative morbidity compared to surgical biopsy.
• Outpatient Convenience: Performed predominantly in outpatient day-care settings under local anaesthesia, avoiding prolonged hospitalization and general anaesthetic risks.
• Enables Precision Medicine: Yields tissue samples optimized for next-generation genetic sequencing, biomarker assessment (such as EGFR, ALK, or PD-L1), and targeted oncologic treatment planning.
• Rapid Recovery Window: Allows most patients to resume normal non-strenuous daily activities within 24 to 48 hours post-procedure.

Recovery following an image-guided biopsy is typically brief and managed in an outpatient setting. Immediately post-procedure, the patient is monitored in a recovery bay for 1 to 4 hours, depending on the anatomical organ sampled. Vital signs and puncture site integrity are systematically evaluated. For thoracic or lung biopsies, post-procedural chest radiography is performed to rule out asymptomatic pneumothorax. Mild local soreness, bruising, or discomfort at the entry site is common and generally responds well to over-the-counter analgesics such as acetaminophen. Patients are instructed to avoid heavy lifting, strenuous exercise, and immersion in baths or hot tubs for 48 to 72 hours. Complete physical recovery typically occurs within 2 to 5 days, coinciding with the timing of definitive pathological reporting.

Image-guided biopsy is routinely performed to evaluate suspicious abnormalities detected on screening or diagnostic imaging across various organ systems. Common indications include:

• Hepatic Masses: Evaluation of primary liver lesions, focal nodular hyperplasia, or suspected metastatic carcinoma.
• Pulmonary Nodules and Mediastinal Lesions: Diagnosis of indeterminate lung nodules, parenchymal infiltrates, or hilar lymphadenopathy.
• Renal Lesions: Differentiation between benign renal masses, oncocytomas, and renal cell carcinoma subtypes.
• Breast Abnormalities: Evaluation of non-palpable microcalcifications, solid masses, or architectural distortions detected on mammography, ultrasound, or MRI.
• Thyroid Nodules: Assessment of thyroid nodules presenting with high-risk features on thyroid ultrasonography.
• Musculoskeletal and Soft Tissue Tumors: Diagnostic sampling of deep retroperitoneal, soft tissue, or osseous masses.
• Lymphadenopathy: Tissue sampling of cervical, axillary, retroperitoneal, or inguinal lymph nodes for lymphoma staging or infectious workups.

Pre-procedural preparation for an image-guided biopsy begins with a pre-assessment of patient health history, active medications, and blood clotting parameters. Laboratory evaluation typically includes a complete blood count (CBC), Prothrombin Time (PT/INR), and Activated Partial Thromboplastin Time (aPTT) to evaluate bleeding risk. According to the Society of Interventional Radiology (SIR) guidelines, antiplatelet and anticoagulant medications (such as aspirin, clopidogrel, warfarin, dabigatran, apixaban, or rivaroxaban) must be withheld for specific clinical windows prior to the procedure under clinician supervision.

Patients are generally instructed to fast (no solid foods) for 4 to 6 hours prior to the scheduled biopsy time, although clear liquids may be allowed up to 2 hours beforehand depending on sedation plans. On the day of the procedure, comfortable clothing should be worn, and a responsible adult companion must be present to assist with transport home following sedated procedures. Patients with known allergies to local anaesthetics, iodinated contrast media, or latex must notify the medical team prior to entering the procedure suite.

Image-guided biopsy is a safe diagnostic technique, but like all invasive procedures, it carries inherent clinical risks. Common, mild side effects include localized pain, minor subcutaneous bruising, hematoma formation at the needle entry site, and transient post-procedural fatigue. Uncommon risks include minor localized bleeding within the target organ (such as transient, mild hemoptysis after lung biopsy or microscopic hematuria following renal biopsy) and localized procedural site infection.

Rare but serious complications include severe internal hemorrhage requiring blood transfusion or transcatheter embolization, damage to adjacent organs or neurovascular bundles, needle-track tumor seeding (occurring in less than 0.1% to 0.3% of cases according to broad clinical registry data), and severe allergic reactions to local anaesthetic agents or contrast media. Specific to lung biopsies, pneumothorax (lung collapse) occurs in 10% to 25% of parenchymal procedures, with roughly 2% to 5% requiring temporary placement of a small chest tube to evacuate trapped air.

The clinical care pathway for an image-guided biopsy begins with a comprehensive pre-procedural assessment, including clinical history evaluation, imaging review, and coagulation profiling. On the day of the procedure, the patient is positioned on an imaging table where local anaesthesia—and occasionally light conscious sedation—is administered to ensure comfort. Real-time guidance using ultrasound, CT, fluoroscopy, or MRI directs the biopsy needle precisely into the target area. Multiple core samples or fluid aspirates are collected, often followed by a rapid on-site evaluation (ROSE) by a cytopathologist to confirm specimen adequacy. Following needle removal and local site compression, the patient undergoes a brief post-procedural monitoring period (typically 1 to 4 hours) to monitor for potential acute complications such as localized bleeding or air leaks. Most patients are discharged the same day with specific care instructions and return for follow-up pathology discussions within several days.